000			01464 a2200409 4500
005			20250515025825.0
264		0	_c20060608
008			200606s 0 0 eng d
022			_a1389-4501
024	7		_a10.2174/138945006776818728 _2doi
040			_aNLM _beng _cNLM
100	1		_aHalayko, A J
245	0	0	_aAirway smooth muscle phenotype and function: interactions with current asthma therapies. _h[electronic resource]
260			_bCurrent drug targets _cMay 2006
300			_a525-40 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdrenergic beta-Agonists _xpharmacology
650	0	4	_aAnti-Asthmatic Agents _xpharmacology
650	0	4	_aAsthma _xdrug therapy
650	0	4	_aBronchi _xdrug effects
650	0	4	_aBronchial Hyperreactivity _xphysiopathology
650	0	4	_aCell Proliferation _xdrug effects
650	0	4	_aCholinergic Antagonists _xpharmacology
650	0	4	_aGene Expression Regulation
650	0	4	_aGlucocorticoids _xpharmacology
650	0	4	_aHumans
650	0	4	_aMuscle Contraction
650	0	4	_aMyocytes, Smooth Muscle _xdrug effects
650	0	4	_aPhenotype
650	0	4	_aTrachea _xdrug effects
700	1		_aTran, T
700	1		_aJi, S Y
700	1		_aYamasaki, A
700	1		_aGosens, R
773	0		_tCurrent drug targets _gvol. 7 _gno. 5 _gp. 525-40
856	4	0	_uhttps://doi.org/10.2174/138945006776818728 _zAvailable from publisher's website
999			_c16317651 _d16317651